A similar destabilizing effect of ISGylation on a leukemic oncoprotein is suggested for the BCR‐ABL kinase that drives chronic myeloid leukemia (CML). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.